About: Irinotecan plus raltitrexed vs raltitrexed alone in patients with gemcitabine-pretreated advanced pancreatic adenocarcinoma

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Irinotecan plus raltitrexed vs raltitrexed alone in patients with gemcitabine-pretreated advanced pancreatic adenocarcinoma Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on April 22, 2003

Attributes	Values
rdf:type	Item
description	article científic (ca) articol științific (ro) artigo científico (gl) scienca artikolo (eo) vitenskapelig artikkel (nb) vitskapeleg artikkel (nn) מאמר מדעי (he) artikel ilmiah (id) мақолаи илмӣ (tg-cyrl) বৈজ্ঞানিক নিবন্ধ (bn) artículu científicu espublizáu en 2003 (ast) maqolai ilmiy (tg-latn) 2003년 논문 (ko) 2003 nî ê lūn-bûn (nan) 2003年の学術論文 (ja) 2003年学术文章 (zh-cn) 2003年学术文章 (zh-sg) 2003年学术文章 (zh-hans) 2003年学术文章 (wuu) 2003年学术文章 (zh-my) 2003年學術文章 (zh) 2003年學術文章 (zh-hk) 2003年學術文章 (zh-tw) 2003年學術文章 (zh-hant) 2003年學術文章 (yue) 2003年學術文章 (zh-mo) наукова стаття, опублікована 22 квітня 2003 (uk) 22 Nisan 2003'de yayımlanmış bilimsel makale (tr) научна статия, публикувана на 22 април 2003 г. (bg) artigo científico publicado em 22 de abril de 2003 (pt) artigo científico publicado em 22 de abril de 2003 (pt-br) article scientifique publié le 22 avril 2003 (fr) articolo scientifico pubblicato il 22 aprile 2003 (it) artikull shkencor i botuar më 22 prill 2003 (sq) artykuł naukowy opublikowany 22 kwietnia 2003 (pl) scientific article published on 22 April 2003 (en-gb) scientific article published on April 22, 2003 (en) vedecký článok publikovaný 22. apríla 2003 (sk) vetenskaplig artikel publicerad den 22 april 2003 (sv) vědecký článek publikovaný 22. dubna 2003 (cs) znanstveni članek objavljen 22. april 2003 (sl) videnskabelig artikel offentliggjort den 22. april 2003 (da) bài báo khoa học xuất bản ngày 22 tháng 4, 2003 (vi) mokslinis straipsnis, publikuotas 2003 m. balandžio 22 d. (lt) wetenschappelijk artikel gepubliceerd op 22 april 2003 (nl) научная статья опубликованная 22 апреля 2003 г. (ru) im 22. April 2003 veröffentlichter wissenschaftlicher Artikel (de) artículo científico publicado el 22 de abril de 2003 (es) научни чланак објављен 22. април 2003. (sr) научни чланак објављен 22. април 2003. (sr-ec) مقالة علمية نشرت في أبريل 2003 (ar)
publication date	wds:Q37355035-0A84F5D5-2BFE-4E85-B917-04B5F7A82303 wds:Q37355035-1BD06C73-D2D9-4BD4-92CD-643E81F4CE19
publication date	2003-04-01 00:00:00Z (xsd:dateTime) 2003-04-22 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37355035-FB5C8DC0-024B-45BF-85E5-FF3A672CDB1D
language of work or name	English
exact match	wds:Q37355035-9AF470B7-91E0-4D2C-ACC7-3B7583F0FA95
exact match	https://scigraph.springernature.com/pub.10.1038/sj.bjc.6600883
cites work	wds:Q37355035-02D9CC4F-81EF-498B-AD64-501A047C9302 wds:Q37355035-0448F6A5-4880-4838-B851-231DCF8C8A66 wds:Q37355035-2D5B3052-5D7D-48A3-B4A7-FF2210AD2E03 wds:Q37355035-2E36AABF-3BD3-4E1A-9EBB-919F956068C5 wds:Q37355035-308547EE-A4D5-4693-8713-A035209C0580 wds:Q37355035-3D0155BF-F4D0-4E58-8940-743AC8045A10 wds:Q37355035-4253D4E6-C607-4B73-AAB2-41CFEDCEC8A3 wds:Q37355035-564CC6BC-B31A-4B9C-8229-AE13317E4253 wds:Q37355035-5CFC1A51-09AA-421F-8B0F-14DB7E3C897B wds:Q37355035-6080564B-9916-4701-9418-40604946E000 wds:Q37355035-61BDD78C-EB12-4494-9C05-EE1D11A3A46F wds:Q37355035-6BC31044-A390-4E1A-A62F-5CD2785D4A0A wds:Q37355035-7437C590-46AF-4228-9349-F8930B209ADB wds:Q37355035-83878BCF-B537-479A-AE85-B39386F06F1E wds:Q37355035-ADBA8054-2891-4DCB-9B30-7AD895561735 wds:Q37355035-B537ADD5-AF69-4B14-AA6E-FB0C11C9B646 wds:Q37355035-B9E4B980-9C8E-4426-885C-AC656C68834D wds:Q37355035-D25C826C-70AE-4912-97FC-E30BEB01DCCC wds:Q37355035-D7799032-9C48-4E19-AA79-8C635F6DD9D6 wds:Q37355035-F2506E41-E319-4ED5-A360-15D00FC5F529 wds:Q37355035-FA58822C-D93D-4072-8463-2B906AA0EE35
cites work	Reporting results of cancer treatment Optimal two-stage designs for phase II clinical trials Nonparametric Estimation from Incomplete Observations Chemotherapy of adenocarcinoma of the pancreas Raltitrexed: current clinical status and future directions Multicenter randomized phase III trial comparing protracted venous infusion (PVI) fluorouracil (5-FU) with PVI 5-FU plus mitomycin in inoperable pancreatic cancer Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer Chemotherapy prolongs survival in inoperable pancreatic carcinoma. Some Methods for Strengthening the Common χ 2 Tests Cancer statistics, 1996. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial A study of 9-nitrocamptothecin (RFS-2000) in patients with advanced pancreatic cancer Gemcitabine-based combination treatment of pancreatic cancer Paclitaxel as weekly second-line therapy in patients with advanced pancreatic carcinoma. Phase I clinical and pharmacogenetic trial of irinotecan and raltitrexed administered every 21 days to patients with cancer Irinotecan(Campto R): efficacy as third/forth line therapy in advanced pancreatic cancer Irinotecan combined with gemcitabine, 5-fluorouracil, leucovorin, and cisplatin (G-FLIP) is an effective and noncrossresistant treatment for chemotherapy refractory metastatic pancreatic cancer Phase II trial of ZD1694 (Tomudex) in patients with advanced pancreatic cancer A phase II trial of biweekly high dose gemcitabine for patients with metastatic pancreatic adenocarcinoma

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software